| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 04/19/2005 | US6881727 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 04/14/2005 | WO2005033930A2 Process for upgrading naphtha |
| 04/14/2005 | WO2005033342A1 Detection of immobilized nucleic acid |
| 04/14/2005 | WO2005033288A2 Hedgehog pathway antagonists |
| 04/14/2005 | WO2005033106A1 Azolidinecarbonitriles and their use as dpp-iv inhibitors |
| 04/14/2005 | WO2005033105A2 Vanilloid receptor ligands and their use in treatments |
| 04/14/2005 | WO2005033104A1 Use of a compound of formula (i) as an inhibitor of aromatase for therapeutic purposes and compounds of formula (1) thereas |
| 04/14/2005 | WO2005033102A2 Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 04/14/2005 | WO2005033099A2 Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof |
| 04/14/2005 | WO2005033093A1 7,8-bicycloalkyl-chroman derivatives |
| 04/14/2005 | WO2005033092A1 Chroman derivatives |
| 04/14/2005 | WO2005032548A1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
| 04/14/2005 | WO2005032493A2 Amide compounds as ion channel ligands and uses thereof |
| 04/14/2005 | WO2005016883A3 Acrylamide derivatives as vla-1 integrin antagonists and uses thereof |
| 04/14/2005 | WO2005007111A3 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 04/14/2005 | WO2005005424B1 Aztreonam l-lysine and methods for the preparation thereof |
| 04/14/2005 | WO2004092124A3 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 04/14/2005 | WO2004013120A8 Novel benzodioxoles |
| 04/14/2005 | US20050080272 Halogenated nitrobutadienes for controlling animal pests |
| 04/14/2005 | US20050080265 Sleep disorders; side effect reduction |
| 04/14/2005 | US20050080121 for example, 4S-[(naphthalene-2-carbonyl)-amino]-5-(2-oxo-pyrrolidin-3S-yl)-pent-2-enoic acid ethyl ester; treatment of viral infections caused by human rhinoviruses, human polioviruses, human coxsackieviruses, human echoviruses, among others |
| 04/14/2005 | US20050080117 Substituted benzoxazoles as estrogenic agents |
| 04/14/2005 | US20050080114 Crystallization of rosiglitazone maleate; SUITABLE FOR BULK PREPARATION AND HANDLING; industrial scale production; hypoglycemic agents; treating diabetes |
| 04/14/2005 | US20050080113 Medicinal compositions |
| 04/14/2005 | US20050080111 Antagonists of liver X receptors; control of cholesterol, triglyceride, or bile acid levels; 6-(1-Benzyl-1H-pyrazol-4-yl)-1-(2,4-difluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile |
| 04/14/2005 | US20050080110 Treating Type 2 diabetes and/or obesity; compounds are indoles substituted at position 3 with a (3-(2-(heterocycle-substituted)phenoxy)-2-hydroxypropylamino)alkyl group |
| 04/14/2005 | US20050080106 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes |
| 04/14/2005 | US20050080101 N-[4-(pyrazolyl)-pyrimidin-2-yl]-N-phenyl-amine derivatives |
| 04/14/2005 | US20050080095 Novel amides useful for treating pain |
| 04/14/2005 | US20050080082 Potassium channel modulators |
| 04/14/2005 | US20050080075 Formulations, conjugates, and combinations of drugs for the treatment of neoplasms |
| 04/14/2005 | US20050080072 Such as 11-[4-[2-(2-hydroxyethoxy)ethyl]-1-pinerazinyl]dibenzo[b,f][1,4]thiazepine (quetiapine) via reduction, cyclization, and deprotection |
| 04/14/2005 | US20050079456 Forms an azomethine dye upon a coupling reaction with an oxidized product of a developing agent; excellent in color reproducibility and image storability |
| 04/14/2005 | DE10342503A1 Benzyl-Benzimidazolylderivate Benzyl-Benzimidazolylderivate |
| 04/14/2005 | CA2541299A1 Amide compounds as ion channel ligands and uses thereof |
| 04/14/2005 | CA2540640A1 Vanilloid receptor ligands and their use in treatments |
| 04/14/2005 | CA2540517A1 Process for upgrading naphtha |
| 04/14/2005 | CA2540508A1 Detection of immobilized nucleic acid |
| 04/14/2005 | CA2540502A1 Use of a compound of formula (i) as an inhibitor of aromatase for therapeutic purposes and compounds of formula (1) thereas |
| 04/14/2005 | CA2539748A1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
| 04/13/2005 | EP1522540A1 Azaarene derivatives |
| 04/13/2005 | EP1521753A2 A process to prepare pioglitazone via several intermediates. |
| 04/13/2005 | EP1521752A1 Novel macrocycles for the treatment of cancer |
| 04/13/2005 | EP1521751A1 Substituted 3-cyanoquinolines as mek inhibitors |
| 04/13/2005 | EP1521750A1 Novel macrocycles for the treatment of cancer diseases |
| 04/13/2005 | EP1521747A2 Receptor-type kinase modulators and methods of use |
| 04/13/2005 | EP1465881A4 Hydrogenation of precursors to thiazolidinedione antihyperglycemics |
| 04/13/2005 | EP1289955B1 Piperidines for use as orexin receptor antagonists |
| 04/13/2005 | EP1244641B1 Thiazolyl amide derivatives |
| 04/13/2005 | EP1134222B1 IMIDAZO[4,5-b]PYRIDINIUMMETHYL-CONTAINING CEPHEM COMPOUNDS HAVING BROAD ANTIBACTERIAL SPECTRUM |
| 04/13/2005 | CN1606560A Novel benzothiazine and benzothiadiazine derivatives, method for preparing same, their use and pharmaceutical compositions containing same |
| 04/13/2005 | CN1606554A Beta-lactamyl vasopressin v1aantagonists |
| 04/13/2005 | CN1606553A Oxytocin agonistenoxytocin agonisten |
| 04/13/2005 | CN1606443A Substituted diketopiperazines as oxytocin antagonists |
| 04/13/2005 | CN1196700C Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 04/13/2005 | CN1196699C Benzazoles: benzoxazole, benzthiazole and benzimidazole derivatives |
| 04/13/2005 | CN1196698C Epothilone C. D. E and F, production process, and their use as cytostatic as well as phytosanitary agents |
| 04/13/2005 | CN1196697C Thiophene-ethyl thiourea compounds and their use in treatment of HIV |
| 04/13/2005 | CN1196689C Continuous process for prepn. of pesticidal chorothiazoles |
| 04/13/2005 | CN1196688C Intermediate for synthetizing thiazolium derivative and its prepn. method |
| 04/13/2005 | CN1196687C Inhibitors of IMPDH enzyme |
| 04/12/2005 | US6878848 Process for converting a cis-trans mixture of substituted benzylidene amines into the pure cis isomer |
| 04/12/2005 | US6878743 Controlling apoptosis; central nervous system disorders |
| 04/12/2005 | US6878734 Gastrin and cholecystokinin receptor ligands(II) |
| 04/12/2005 | US6878729 Antihypoxic agents |
| 04/12/2005 | US6878727 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 04/12/2005 | US6878725 Serine protease inhibitors |
| 04/12/2005 | US6878714 Prophylaxis and treatment of angiogenesis mediated diseases such as cancer |
| 04/12/2005 | US6878709 Treating acute and chronic inflammatory disorders and cancer. |
| 04/12/2005 | US6878704 Heterocyclic mutilin esters and their use as antibacterials |
| 04/12/2005 | CA2174107C Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones |
| 04/12/2005 | CA2127193C 2-[1-(1,3-thiazolin-2-yl)azetidin-3-yl] thio-carbapenem derivatives |
| 04/12/2005 | CA2081836C Aromatic amidine derivatives and salts thereof |
| 04/07/2005 | WO2005030767A1 Novel macrocycles for treating tumor diseases |
| 04/07/2005 | WO2005030766A1 Phenyl - carboxamide compounds useful for treating pain |
| 04/07/2005 | WO2005030762A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 04/07/2005 | WO2005030761A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 04/07/2005 | WO2005030758A1 Pyrimidine and pyridine derivatives useful as hmg-coa reductase inhibitors and method of preparation thereof |
| 04/07/2005 | WO2005030755A1 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| 04/07/2005 | WO2005030754A1 Indole or quinoline derivatives as non-pepticid npy y2 receptor inhibitors useful for the treatment of anxiolytic and depressive disorders and obesity |
| 04/07/2005 | WO2005030753A2 Therapeutic agents useful for treating pain |
| 04/07/2005 | WO2005030739A1 Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof |
| 04/07/2005 | WO2005030735A1 Triazines derivatives as cell adhesion inhibitors |
| 04/07/2005 | WO2005030731A1 Gamma-secretase inhibitors |
| 04/07/2005 | WO2005030729A1 Isoquinoline potassium channel inhibitors |
| 04/07/2005 | WO2005030727A1 Isoquinolinone potassium channel inhibitors |
| 04/07/2005 | WO2005030725A1 Derivatives of 3-aminocarbonylquinoline, pharmaceutical compositions containing them and processes and intermediates for their preparation |
| 04/07/2005 | WO2005030716A1 Heterocyclic- or aryloxy, -thio or -amino substituted indoles-2-carboxylic acids or esters as pai-1 |
| 04/07/2005 | WO2005030712A2 Thrombin receptor antagonists |
| 04/07/2005 | WO2005030705A1 Inhibitors of histone deacetylase |
| 04/07/2005 | WO2005030704A1 Inhibitors of histone deacetylase |
| 04/07/2005 | WO2005030206A1 Aryl-1,3-azole derivatives and methods for inhibiting heparnase activity |
| 04/07/2005 | WO2005030131A2 Bis-quinazoline compounds for the treatment of bacterial infections |
| 04/07/2005 | WO2005016918A3 Heterocyclic n-aryl carboxamides as cytokine inhibitors |
| 04/07/2005 | WO2005007647A9 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 04/07/2005 | WO2005000249A3 Preparation of chemical compounds |
| 04/07/2005 | WO2004112719A3 Chemical compounds |
| 04/07/2005 | WO2004112709A3 Inhibitors of cathepsin s |
| 04/07/2005 | WO2004014871A8 Vanilloid receptor ligands and their use in treatments |
| 04/07/2005 | US20050075390 HIV protease inhibitors |